Pulmonary Sarcoidosis following Etanercept Treatment
Tumour necrosis factor (TNF) is an important cytokine involved in the pathology of a number of inflammatory conditions, and thus blockade with anti-TNF therapies is becoming the cornerstone in managing such diseases. With increasing use, evidence is collected for the association of sarcoid-like gran...
Saved in:
| Main Authors: | Kuljeet Bhamra, Richard Stevens |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2012/724013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Sarcoidosis following Etanercept Treatment for Ankylosing Spondylitis: A Case Report and Review of the Literature
by: A. Majjad, et al.
Published: (2018-01-01) -
Etanercept in axial spondyloarthritis – treatment efficacy
by: I. Z. Gaydukova, et al.
Published: (2022-03-01) -
Etanercept (Enbrel) in the treatment of psoriatic arthritis
by: T V Korotaeva
Published: (2009-12-01) -
Experience of etanercept treatment in juvenile ankylosing spondyloarthritis
by: A. N. Fetisova, et al.
Published: (2013-03-01) -
Rheumatoid Meningitis Occurring during Etanercept Treatment
by: Koji Tsuzaki, et al.
Published: (2017-01-01)